Status:
COMPLETED
Effects of Reparel™ Knee Sleeve on Knee Osteoarthritis
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The goals of treating knee osteoarthritis (OA) is to improve or maintain quality of life, mobility and function, pain relief, and improve inflammation. The different treatment options for knee OA have b...
Detailed Description
Standard knee compression sleeves have been described throughout literature to provide benefits in pain and functional outcomes through support of the ligamentous structures. Bracing is both an effectiv...
Eligibility Criteria
Inclusion
- osteoarthritis visible on knee radiograph
- patient opting for non-surgical treatment
- no corticosteroid knee injection for 90 days prior to consent
- no corticosteroid knee injection for 90 days following consent
Exclusion
- bilateral symptomatic knee osteoarthritis
- prior surgery on the knee of interest
- hardware present on the knee of interest
- gross instability detected on physical exam
- malignancy in the knee of question
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 6 2021
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04743921
Start Date
February 1 2021
End Date
November 6 2021
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UAB Hospital Highlands
Birmingham, Alabama, United States, 35205